ZA881657B - Sustained release compositions for parenteral administration and their use - Google Patents

Sustained release compositions for parenteral administration and their use

Info

Publication number
ZA881657B
ZA881657B ZA881657A ZA881657A ZA881657B ZA 881657 B ZA881657 B ZA 881657B ZA 881657 A ZA881657 A ZA 881657A ZA 881657 A ZA881657 A ZA 881657A ZA 881657 B ZA881657 B ZA 881657B
Authority
ZA
South Africa
Prior art keywords
biologically active
sustained release
parenteral administration
increasing
release compositions
Prior art date
Application number
ZA881657A
Other languages
English (en)
Inventor
Dietrich Arendt Volker
Original Assignee
American Cyanamid Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Company filed Critical American Cyanamid Company
Publication of ZA881657B publication Critical patent/ZA881657B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/813—Carrier is a saccharide
    • Y10S530/814—Cellulose or derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA881657A 1987-03-09 1988-03-08 Sustained release compositions for parenteral administration and their use ZA881657B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/023,427 US4857505A (en) 1987-03-09 1987-03-09 Sustained release compositions for parenteral administration and their use

Publications (1)

Publication Number Publication Date
ZA881657B true ZA881657B (en) 1988-09-06

Family

ID=21815030

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA881657A ZA881657B (en) 1987-03-09 1988-03-08 Sustained release compositions for parenteral administration and their use

Country Status (14)

Country Link
US (1) US4857505A (de)
EP (1) EP0281809B1 (de)
JP (1) JPS63253030A (de)
AT (1) ATE92329T1 (de)
AU (1) AU603189B2 (de)
CA (1) CA1318249C (de)
DE (1) DE3882748D1 (de)
DK (1) DK124288A (de)
FI (1) FI881061A (de)
GR (1) GR3009565T3 (de)
HU (1) HU201681B (de)
IL (1) IL85476A (de)
NZ (1) NZ223715A (de)
ZA (1) ZA881657B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336506A (en) * 1986-07-03 1994-08-09 Advanced Magnetics Inc. Targeting of therapeutic agents using polysaccharides
US4929670A (en) * 1987-10-26 1990-05-29 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5011918A (en) * 1987-10-26 1991-04-30 National Starch And Chemical Investment Holding Corporation Polysaccharides containing aromatic aldehydes and their derivatization via amine-aldehyde interactions
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5637566A (en) * 1988-08-24 1997-06-10 Southern Cross Biotech Pty. Ltd. Method of improving carcass quality by administering growth hormone
US5174998A (en) * 1988-11-30 1992-12-29 Nisshin Flour Milling Co., Ltd. Sustained release compositions using as matrix hemicellulose extracted from wheat bran
US5032401A (en) * 1989-06-15 1991-07-16 Alpha Beta Technology Glucan drug delivery system and adjuvant
US5374620A (en) * 1990-06-07 1994-12-20 Genentech, Inc. Growth-promoting composition and its use
US5126324A (en) * 1990-06-07 1992-06-30 Genentech, Inc. Method of enhancing growth in patients using combination therapy
US5681814A (en) * 1990-06-07 1997-10-28 Genentech, Inc. Formulated IGF-I Composition
US5733891A (en) * 1990-10-18 1998-03-31 Shiseido Co., Ltd. Compound for medicinal ingredient and hyaluronic acid and process for producing the same
DE69125595T2 (de) * 1990-10-18 1997-11-13 Shiseido Co. Ltd., Tokio/Tokyo Kombination von hyaluronsäure mit einem medizinischen bestandteil, und seine herstellung
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
EP0563249B1 (de) * 1990-12-19 1997-04-23 Advanced Magnetics Incorporated Targeting von therapeutischen mitteln durch verwendung von polysacchariden
US5344644A (en) * 1991-08-01 1994-09-06 Takeda Chemical Industries, Ltd. Water-soluble composition for sustained-release
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
US5643867A (en) * 1992-08-26 1997-07-01 Celtrix Pharmaceuticals, Inc. Method for treating catabolic conditions
US6284727B1 (en) * 1993-04-07 2001-09-04 Scios, Inc. Prolonged delivery of peptides
US5614487A (en) * 1993-05-28 1997-03-25 Genentech, Inc. Sustained release pharmaceutical composition
US6214331B1 (en) 1995-06-06 2001-04-10 C. R. Bard, Inc. Process for the preparation of aqueous dispersions of particles of water-soluble polymers and the particles obtained
ATE386501T1 (de) * 1999-07-12 2008-03-15 Sandoz Ag Formulierungen von wachstumshormonen
CN1095472C (zh) 2000-04-17 2002-12-04 上海复康医药科技发展有限公司 叶酸－多聚糖复合物，其制备方法和以该复合物为活性成分的药物组合物
CN102180944A (zh) * 2001-10-10 2011-09-14 诺和诺德公司 肽的重构和糖缀合
MXPA05000413A (es) * 2002-07-09 2005-07-22 Sandoz Ag Formulaciones liquidas con una alta concentracion de hormona de crecimiento humana (hgh) que comprenden 1,2-propilenglicol.
CN113398273B (zh) * 2021-05-14 2022-07-19 广西壮族自治区中国科学院广西植物研究所 木聚糖衍生物作为亲水性缓释材料在制备药物缓释片中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH514650A (fr) * 1967-05-23 1971-10-31 Pharmacia Ab Procédé de préparation de dérivés de peptides insolubles dans l'eau
US4003792A (en) * 1967-07-01 1977-01-18 Miles Laboratories, Inc. Conjugates of acid polysaccharides and complex organic substances
US3947352A (en) * 1974-05-31 1976-03-30 Pedro Cuatrecasas Polysaccharide matrices for use as adsorbents in affinity chromatography techniques
CA1167403A (en) * 1979-07-10 1984-05-15 Unilever Limited Microbial heteropolysaccharide
EP0085036A1 (de) * 1982-01-18 1983-08-03 Monsanto Company Verfahren zur Verbesserung der Rindermilchproduktion
US4521409A (en) * 1983-10-03 1985-06-04 Cornell Research Foundation, Inc. Use of growth hormone to enhance ruminant mammary development
US4585754A (en) * 1984-01-09 1986-04-29 Valcor Scientific, Ltd. Stabilization of proteins and peptides by chemical binding with chondroitin
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
EP0193917A3 (de) * 1985-03-06 1987-09-23 American Cyanamid Company Wasserdispersible und wasserlösliche Polymerzusammensetzungen für parenterale Anwendung
AU6073386A (en) * 1985-07-30 1987-02-05 International Minerals & Chemical Corporation Stabilization of growth promoting hormones
CA1285874C (en) * 1985-08-23 1991-07-09 Thomas Harry Ferguson Injectable sustained release formulation
EP0257368B1 (de) * 1986-08-11 1992-03-25 American Cyanamid Company Zusammensetzungen zur parenteralen Verabreichung und deren Verwendung

Also Published As

Publication number Publication date
IL85476A0 (en) 1988-07-31
EP0281809A3 (en) 1990-06-06
IL85476A (en) 1991-08-16
DK124288D0 (da) 1988-03-08
CA1318249C (en) 1993-05-25
FI881061A (fi) 1988-09-10
DK124288A (da) 1988-09-10
AU603189B2 (en) 1990-11-08
EP0281809B1 (de) 1993-08-04
FI881061A0 (fi) 1988-03-08
AU1277688A (en) 1988-09-08
ATE92329T1 (de) 1993-08-15
HU201681B (en) 1990-12-28
HUT47220A (en) 1989-02-28
DE3882748D1 (de) 1993-09-09
NZ223715A (en) 1990-11-27
US4857505A (en) 1989-08-15
EP0281809A2 (de) 1988-09-14
JPS63253030A (ja) 1988-10-20
GR3009565T3 (de) 1994-02-28

Similar Documents

Publication Publication Date Title
IL85476A0 (en) Sustained release compositions for parenteral administration and their use
AU1017088A (en) Sustained release growth hormone compositions for parenteral administration and their use
ES8704347A1 (es) Procedimiento de obtencion de composiciones a base de polimeros de carbohidratos solubles y dispersables en agua
ES2007414A6 (es) Procedimiento de produccion de productos naturales antioxidantes para fines mediocos.
AU6020186A (en) Process for production of dry bioactive recombinant growth hormones
HK1072894A1 (en) The use of epidermal growth factor (egf) for increasing weight gain in an animal
JPS6423858A (en) Animal feed additive, feed containing the same and animal growth improving method
EP0308197A3 (de) Verfahren zur Stimulierung des Immunsystems
ES2012128A6 (es) Metodo de tratar plantas con acidos organicos que contienen azufre.
DE3760489D1 (en) Aroma composition, the use thereof and the process for the preparation thereof
GR3004303T3 (de)
GR3002583T3 (en) Process for stimulating the growth and the health of crops
MD277C2 (ro) Preparat microbicid
ATE84194T1 (de) Vitamin u und verfahren zur behandlung von tieren mit vitamin u.
JPS6452792A (en) Production of blood platelet growth factor
SU1471341A1 (ru) Состав для регулирования роста облепихи
HUT57689A (en) Process for increasing yields in plant cultivation and for improving the quality of crop
CA2127445A1 (en) Nutrient composition
IT1209053B (it) Materiale conglomerabile per la realizzazione di manufatti erelativo procedimento diformazione.